UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial

Gut, 2011-06, Vol.60 (6), p.765-773

2011

Volltextzugriff (PDF)

EUS-GUIDED DRAINAGE OF PANCREATIC PSEUDOCYSTS, ABSCESSES AND INFECTED NECROSIS

Digestive endoscopy, 2009-07, Vol.21 (s1), p.S61-S65

2009

Volltextzugriff (PDF)

Dose-Dependent Pharmacokinetics of Itraconazole after Intravenous or Oral Administration to Rats: Intestinal First-Pass Effect

Antimicrobial Agents and Chemotherapy, 2004-05, Vol.48 (5), p.1756-1762

2004

Volltextzugriff (PDF)

Pharmacokinetics of DA‐8159, a New Erectogenic, after Intravenous and Oral Administration to Rats: Hepatic and Intestinal First‐Pass Effects

Journal of pharmaceutical sciences, 2003-11, Vol.92 (11), p.2185-2195

2003

Volltextzugriff (PDF)

Effect of CYP3A1(23) Induction on Clarithromycin Pharmacokinetics in Rats with Diabetes Mellitus

Antimicrobial Agents and Chemotherapy, 2005-06, Vol.49 (6), p.2528-2532

2005

Volltextzugriff (PDF)

Elevated Plasma Osteopontin Levels in Patients with Hepatocellular Carcinoma

The American journal of gastroenterology, 2006-09, Vol.101 (9), p.2051-2059

2006

Volltextzugriff (PDF)

Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics

Biopharmaceutics & drug disposition, 2005-10, Vol.26 (7), p.269-277

2005

Volltextzugriff (PDF)

Subacute toxicities and toxicokinetics of DA-8159, a new phosphodiesterase type V inhibitor, after single and 4-Week repeated oral administration in rats

Biopharmaceutics & drug disposition, 2003-12, Vol.24 (9), p.409-418

2003

Volltextzugriff (PDF)

Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin

Biopharmaceutics & drug disposition, 2006-03, Vol.27 (2), p.85-92

2006

Volltextzugriff (PDF)

Pharmacokinetics of phenytoin and its metabolite, 4′-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin

Biopharmaceutics & drug disposition, 2008-01, Vol.29 (1), p.51-61

2008

Volltextzugriff (PDF)

Pharmacokinetic changes of DA‐8159, a new erectogenic, after intravenous and oral administration to rats with diabetes mellitus induced by streptozotocin

Journal of pharmaceutical sciences, 2004-09, Vol.93 (9), p.2374-2387

2004

Volltextzugriff (PDF)

Mechanism of enhanced bioavailability and diuretic effect of azosemide by ascorbic acid in rats

Life sciences (1973), 2006-02, Vol.78 (10), p.1057-1062

2006

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin

Biopharmaceutics & drug disposition, 2005-11, Vol.26 (8), p.371-378

2005

Volltextzugriff (PDF)

Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats

International journal of pharmaceutics, 2005-05, Vol.296 (1), p.94-102

2005

Volltextzugriff (PDF)

Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA-8159, a new erectogenic, in rats

Biopharmaceutics & drug disposition, 2005-09, Vol.26 (6), p.233-241

2005

Volltextzugriff (PDF)

Dose-independent pharmacokinetics of torasemide after intravenous and oral administration to rats

Biopharmaceutics & drug disposition, 2005-07, Vol.26 (5), p.173-182

2005

Volltextzugriff (PDF)

Pharmacokinetics of intravenous and oral DA-8159, a new erectogenic, in rats with protein-calorie malnutrition

Journal of pharmacy and pharmacology, 2004-12, Vol.56 (12), p.1543-1550

2004

Volltextzugriff (PDF)

Pharmacokinetic changes of DA-8159, a new erectogenic, and one of its metabolites, DA-8164 after intravenous and oral administration of DA-8159 to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats

Biopharmaceutics & drug disposition, 2005-10, Vol.26 (7), p.309-320

2005

Volltextzugriff (PDF)

Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans

Biopharmaceutics & drug disposition, 2005-05, Vol.26 (4), p.161-166

2005

Volltextzugriff (PDF)

Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with acute renal failure induced by uranyl nitrate

Biopharmaceutics & drug disposition, 2004-04, Vol.25 (3), p.137-142

2004

Volltextzugriff (PDF)

Effects of water deprivation for 72 hours on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats

Biopharmaceutics & drug disposition, 2006-04, Vol.27 (3), p.147-156

2006

Volltextzugriff (PDF)

Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes

Biopharmaceutics & drug disposition, 2003-03, Vol.24 (2), p.53-61

2003

Volltextzugriff (PDF)

Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of torasemide in rabbits

Biopharmaceutics & drug disposition, 2004-07, Vol.25 (5), p.211-218

2004

Volltextzugriff (PDF)

Endoscopic Drainage of Symptomatic Pancreatic Fluid Collections - Immediate and Long-Term Results of a Multi-Center Study

Gastrointestinal endoscopy, 2009-04, Vol.69 (5), p.AB337-AB337

2009

Volltextzugriff (PDF)

Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-8159, a new erectogenic, in rats

Research communications in molecular pathology and pharmacology, 2005, Vol.117-118, p.179

2005

Volltextzugriff (PDF)

1 – 25 von 6.622

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.808)
Mit Volltextzugriff
(5.835)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(4.290)
Life Sciences & Biomedicine
(2.071)
Physical Sciences
(1.549)
Humans
(1.381)
Physics
(1.375)
Technology
(1.214)
Male
(881)
Female
(775)
Animals
(678)
Materials Science
(629)
Biological And Medical Sciences
(623)
Physics Of Elementary Particles And Fields
(528)
Materials Science, Multidisciplinary
(472)
Exact Sciences And Technology
(460)
Middle Aged
(458)
Medical Sciences
(457)
Engineering
(444)
Adult
(412)
Physics, Applied
(398)
Chemistry
(364)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial

EUS-GUIDED DRAINAGE OF PANCREATIC PSEUDOCYSTS, ABSCESSES AND INFECTED NECROSIS

Dose-Dependent Pharmacokinetics of Itraconazole after Intravenous or Oral Administration to Rats: Intestinal First-Pass Effect

Pharmacokinetics of DA‐8159, a New Erectogenic, after Intravenous and Oral Administration to Rats: Hepatic and Intestinal First‐Pass Effects

Effect of CYP3A1(23) Induction on Clarithromycin Pharmacokinetics in Rats with Diabetes Mellitus

Elevated Plasma Osteopontin Levels in Patients with Hepatocellular Carcinoma

Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics

Subacute toxicities and toxicokinetics of DA-8159, a new phosphodiesterase type V inhibitor, after single and 4-Week repeated oral administration in rats

Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin

Pharmacokinetics of phenytoin and its metabolite, 4′-HPPH, after intravenous and oral administration of phenytoin to diabetic rats induced by alloxan or streptozotocin

Pharmacokinetic changes of DA‐8159, a new erectogenic, after intravenous and oral administration to rats with diabetes mellitus induced by streptozotocin

Mechanism of enhanced bioavailability and diuretic effect of azosemide by ascorbic acid in rats

Pharmacokinetics and pharmacodynamics of intravenous torasemide in diabetic rats induced by alloxan or streptozotocin

Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats

Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA-8159, a new erectogenic, in rats

Dose-independent pharmacokinetics of torasemide after intravenous and oral administration to rats

Pharmacokinetics of intravenous and oral DA-8159, a new erectogenic, in rats with protein-calorie malnutrition

Pharmacokinetic changes of DA-8159, a new erectogenic, and one of its metabolites, DA-8164 after intravenous and oral administration of DA-8159 to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats

Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans

Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with acute renal failure induced by uranyl nitrate

Effects of water deprivation for 72 hours on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats

Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes

Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of torasemide in rabbits

Endoscopic Drainage of Symptomatic Pancreatic Fluid Collections - Immediate and Long-Term Results of a Multi-Center Study

Effects of bacterial lipopolysaccharide on the pharmacokinetics of DA-8159, a new erectogenic, in rats

Suchergebnisse filtern